JP2020516671A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516671A5
JP2020516671A5 JP2019556238A JP2019556238A JP2020516671A5 JP 2020516671 A5 JP2020516671 A5 JP 2020516671A5 JP 2019556238 A JP2019556238 A JP 2019556238A JP 2019556238 A JP2019556238 A JP 2019556238A JP 2020516671 A5 JP2020516671 A5 JP 2020516671A5
Authority
JP
Japan
Prior art keywords
methyl
compound
acid
triazole
sulfanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019556238A
Other languages
English (en)
Japanese (ja)
Other versions
JP7241025B2 (ja
JP2020516671A (ja
Filing date
Publication date
Priority claimed from IT102017000041723A external-priority patent/IT201700041723A1/it
Application filed filed Critical
Publication of JP2020516671A publication Critical patent/JP2020516671A/ja
Publication of JP2020516671A5 publication Critical patent/JP2020516671A5/ja
Priority to JP2022164773A priority Critical patent/JP2022191395A/ja
Application granted granted Critical
Publication of JP7241025B2 publication Critical patent/JP7241025B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019556238A 2017-04-14 2018-04-12 選択的hdac6阻害剤 Active JP7241025B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022164773A JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000041723 2017-04-14
IT102017000041723A IT201700041723A1 (it) 2017-04-14 2017-04-14 Nuovi inibitori selettivi di HDAC6
PCT/EP2018/059468 WO2018189340A1 (en) 2017-04-14 2018-04-12 Selective hdac6 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022164773A Division JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Publications (3)

Publication Number Publication Date
JP2020516671A JP2020516671A (ja) 2020-06-11
JP2020516671A5 true JP2020516671A5 (enExample) 2020-12-17
JP7241025B2 JP7241025B2 (ja) 2023-03-16

Family

ID=59700099

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019556238A Active JP7241025B2 (ja) 2017-04-14 2018-04-12 選択的hdac6阻害剤
JP2022164773A Withdrawn JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022164773A Withdrawn JP2022191395A (ja) 2017-04-14 2022-10-13 選択的hdac6阻害剤

Country Status (30)

Country Link
US (1) US11351178B2 (enExample)
EP (1) EP3562810B1 (enExample)
JP (2) JP7241025B2 (enExample)
KR (1) KR102525375B1 (enExample)
CN (1) CN110546140B (enExample)
AR (1) AR111466A1 (enExample)
AU (1) AU2018252172B9 (enExample)
CA (1) CA3056381A1 (enExample)
CL (1) CL2019002869A1 (enExample)
CO (1) CO2019011993A2 (enExample)
CY (1) CY1126110T1 (enExample)
DK (1) DK3562810T3 (enExample)
ES (1) ES2951476T3 (enExample)
FI (1) FI3562810T3 (enExample)
HR (1) HRP20230789T8 (enExample)
HU (1) HUE063079T2 (enExample)
IL (1) IL268955B (enExample)
IT (1) IT201700041723A1 (enExample)
LT (1) LT3562810T (enExample)
MX (1) MX2019011876A (enExample)
NZ (1) NZ756603A (enExample)
PE (1) PE20200446A1 (enExample)
PL (1) PL3562810T3 (enExample)
PT (1) PT3562810T (enExample)
RS (1) RS64376B1 (enExample)
RU (1) RU2764718C2 (enExample)
SI (1) SI3562810T1 (enExample)
SM (1) SMT202300228T1 (enExample)
TW (1) TWI813564B (enExample)
WO (1) WO2018189340A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10357493B2 (en) 2017-03-10 2019-07-23 Selenity Therapeutics (Bermuda), Ltd. Metalloenzyme inhibitor compounds
CN109942564A (zh) * 2019-04-16 2019-06-28 四川大学华西医院 一种组蛋白去乙酰化酶抑制剂及其制备方法和用途
CN115443329A (zh) 2019-06-27 2022-12-06 乔治华盛顿大学国会特许非营利公司 Hdac6激活的巨噬细胞、其组合物及用途
WO2021013163A1 (en) * 2019-07-23 2021-01-28 Taipei Medical University Histone deacetylase 6 inhibitors and method for treating neuropathic pain
CN114727974A (zh) 2019-07-30 2022-07-08 艾科尼佐治疗股份有限公司 Hdac6抑制剂及其用途
KR20220119653A (ko) * 2019-12-20 2022-08-30 테나야 테라퓨틱스, 인코포레이티드 플루오로알킬-옥사디아졸 및 이의 용도
CA3189738A1 (en) * 2020-08-07 2022-02-10 Italfarmaco S.P.A. Novel oxadiazole-based selective hdac6 inhibitors
CN112250638B (zh) * 2020-11-13 2022-05-03 郑州大学 一种1,3-二芳基-1,2,4-三氮唑类化合物及其制备方法和应用
WO2022169985A1 (en) 2021-02-03 2022-08-11 Eikonizo Therapeutics, Inc. Hdac6 inhibitors and uses thereof
IT202100009926A1 (it) * 2021-04-20 2022-10-20 Italfarmaco Spa Una combinazione comprendente un inibitore di hdac6 specifico e almeno un inibitore del checkpoint ctla4
TW202340480A (zh) 2021-11-23 2023-10-16 義大利商義大利藥品股份有限公司 檢測rna生物標記之方法
AU2023250964A1 (en) 2022-04-08 2024-11-07 Eikonizo Therapeutics, Inc. Oxadiazole hdac6 inhibitors and uses thereof
WO2023219456A1 (ko) * 2022-05-12 2023-11-16 숙명여자대학교 산학협력단 퀴놀린 계열 히스톤디아세틸화 효소 저해활성물질, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
KR20240043709A (ko) * 2022-09-27 2024-04-03 사회복지법인 삼성생명공익재단 히스톤 탈아세틸화효소 억제제를 포함하는 암 치료용 조성물, 및 암 면역치료용 항암 보조제
CN115611823B (zh) * 2022-10-27 2024-09-27 新天地医药技术研究院(郑州)有限公司 一种1,2,4-三氮唑-苯基异羟肟酸类化合物、制备方法和应用
CN115737549A (zh) * 2022-11-24 2023-03-07 北京鑫开元医药科技有限公司 一种具有hdac抑制活性的注射液及其制备方法和用途
AU2024206778A1 (en) * 2023-01-06 2025-07-24 Sparrow Pharmaceuticals, Inc. Methods and compositions for treating hsd-1-mediated disorders
CN121108070A (zh) * 2025-09-22 2025-12-12 徐州医科大学 双苯基噁二唑类化合物或其盐、其制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04007191A (es) 2002-01-23 2005-03-31 Bayer Pharmaceuticals Corp Derivados de pirimidina como inhibidores de rho-quinasa.
JP2008504345A (ja) 2004-07-02 2008-02-14 ノボ ノルディスク アクティーゼルスカブ コンデンスチオフェン誘導体(condensedthiophenederivatives)およびそれらのサイクリックGLP−1アゴニストとしての使用
GB0607899D0 (en) 2006-04-03 2006-05-31 Glaxo Group Ltd Process for preparing heterocyclic derivatives
WO2009002534A1 (en) 2007-06-26 2008-12-31 Gilead Colorado, Inc. Imidazopyridinyl thiazolyl histone deacetylase inhibitors
CA2765678A1 (en) 2009-06-22 2010-12-29 Christopher Blackburn Substituted hydroxamic acids and uses thereof
CN102548975A (zh) * 2009-07-07 2012-07-04 安瑟生物科技私人有限公司 组蛋白去乙酰化酶抑制剂
JP5518397B2 (ja) 2009-08-12 2014-06-11 富士フイルム株式会社 水性インク組成物、複合粒子の製造方法、インクセット、及び、画像形成方法
WO2011106650A2 (en) 2010-02-27 2011-09-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
NZ610225A (en) * 2010-11-16 2015-08-28 Acetylon Pharmaceuticals Inc Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
USRE47009E1 (en) * 2011-02-01 2018-08-28 The Children's Hospital Of Philadelphia HDAC inhibitors and therapeutic methods using the same
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
WO2012178208A2 (en) * 2011-06-24 2012-12-27 The Trustees Of The Stevens Institute Of Technology Selective inhibitors of histone deacetylase isoform 6 and methods thereof
HRP20181965T1 (hr) 2013-12-12 2019-02-08 Chong Kun Dang Pharmaceutical Corp. Novi derivati azaindola kao selektivni inhibitori histonske deacetilaze (hdac) i farmaceutski pripravci koji ih sadrže
KR101685639B1 (ko) 2014-01-03 2016-12-12 주식회사 종근당 신규한 인돌 유도체 화합물 및 이를 포함하는 약제학적 조성물
TW201625620A (zh) * 2014-05-14 2016-07-16 美國科羅拉多州立大學 作為蛋白去乙醯酶抑制劑及雙蛋白去乙醯酶蛋白激酶抑制劑之雜環氧肟酸及其使用方法
MX388409B (es) * 2014-06-12 2025-03-19 Cedars Sinai Medical Center Composiciones y metodos para tratar canceres.

Similar Documents

Publication Publication Date Title
RU2019132212A (ru) Селективные ингибиторы hdac6
RU2317291C2 (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение
JP2019517455A5 (enExample)
JP5674828B2 (ja) Pde10インヒビターならびに関連する組成物および方法
RU2439068C2 (ru) Модуляторы mglur5
JP2010533158A5 (enExample)
JP2018535999A5 (enExample)
JP2014511869A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2016164184A5 (enExample)
RU2018138707A (ru) Замещенные гетероарилом пиридины и способы применения
JP2014525444A5 (enExample)
JP2007510689A5 (enExample)
JP2007530690A5 (enExample)
JP2008546836A (ja) 新規な用途
JP2019518036A5 (enExample)
JP2010505809A5 (enExample)
JP2010510242A5 (enExample)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
US20250059173A1 (en) Cardiac sarcomere inhibitors
JP2007523208A5 (enExample)
JP2006503081A5 (enExample)
JP2014513122A5 (enExample)
JP2010513438A5 (enExample)
JP2020500192A5 (enExample)